Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Virulence attenuating combination therapy: a potential multi-target synergy approach to treat Pseudomonas aeruginosa infections in cystic fibrosis patients

1 Jan 2020

Abstract excerpt

infections, outlines the current landscape of synergistic combinations between virulence-targeting small-molecules and anti-pseudomonal drugs, and suggests future directions for VACT research.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibiotic Resistance in Bacteria
Share to Bacterial biofilms and quorum sensing
Share to Cystic Fibrosis Research Advances

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33479641
DOI: 10.1039/c9md00566h

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Virulence attenuating combination therapy: a potential multi-target synergy approach to treat Pseudomonas aeruginosa infections in cystic fibrosis patientsPMID 33479641Read ↗

Pseudomonas aeruginosa in cystic fibrosis: Pathogenesis and new treatmentsSemantic proximity Read ↗

Beyond antibiotics: Emerging antivirulence strategies to combat Pseudomonas aeruginosa in cystic fibrosisSemantic proximity Read ↗

New alternative therapeutic strategies against Pseudomonas aeruginosa, an opportunistic multi-resistant pathogen with a myriad of virulence factors.Semantic proximity Read ↗

Combatting Pseudomonas aeruginosa with β-Lactam Antibiotics: A Revived Weapon?Semantic proximity Read ↗

New Treatments for Emerging Cystic Fibrosis Pathogens other than PseudomonasSemantic proximity Read ↗

Towards Innovative Antibacterial Correctors for Cystic Fibrosis Targeting the Lung Microbiome with a Multifunctional Effect.Semantic proximity Read ↗

The Building Blocks of Antimicrobial Resistance in Pseudomonas aeruginosa: Implications for Current Resistance-Breaking TherapiesSemantic proximity Read ↗

Mitigating the Impact of Antibacterial Drug Resistance through Host-Directed Therapies: Current Progress, Outlook, and ChallengesSemantic proximity Read ↗

Novel Therapeutic Strategies Applied to Pseudomonas aeruginosa Infections in Cystic FibrosisSemantic proximity Read ↗

Development of Quinazolinone Derivatives as Modulators of Virulence Factors of Pseudomonas aeruginosa Cystic Fibrosis StrainsSemantic proximity Read ↗

New strategies for targeting and treatment of multi-drug resistant Staphylococcus aureus.Semantic proximity Read ↗

Antibiotic potentiation and inhibition of cross-resistance in pathogens associated with cystic fibrosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.